Ledger.Open graph →
SEC Form D · filed December 19, 2019

WINDTREE THERAPEUTICS INC /DE/

Offering
$26.4M
Sold
$26.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WARRINGTON, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

James A. Huang · Warrington, PADirectorJoseph M. Mahady · Warrington, PADirectorBrian A. Schreiber · Warrington, PADirectorMary B. Templeton · Warrington, PAExecBruce A. Peacock · Warrington, PADirectorSteven A. Simonson · Warrington, PAExecJohn A. Tattory · Warrington, PAExecCraig E. Fraser · Warrington, PAExec · DirectorJohn R. Leone · Warrington, PADirectorDaniel Geffken · CAMBRIDGE, MADirectorAndrew G. Crawford · New York, NYExec · DirectorTerry S. Sebastian · Moss Landing, CADirectorRob W. Holland · Greenwood Village, COExecChristy A. Shaffer · RESEARCH TRIANGLE PARK, NCDirectorHarold C. Nash · Luxembourg, LuxembourgDirectorRichard S. Pontin · Lowell, MADirectorAndrew Pearson · Greenwich, CTExecGregory N. Mossinghoff · RESEARCH TRIANGLE PARK, NCExec · DirectorDonald L. Dillingham · Oklahoma City, OKExec · DirectorDaniel H. Weintraub · Boston, MADirectorRichard Mott · Redwood City, CADirectorPeter Trovato · Quincy, MAExecAlister W. Reynolds · Boulder, COExec · DirectorLarry Gold · Boulder, COExecCharles K. Huebner · CHICAGO, ILDirectorThomas P. Danis · CHICAGO, ILDirectorDaniel Geffken · W. Concord, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗